摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid

中文名称
——
中文别名
——
英文名称
4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid
英文别名
4-(2-nitro-4-methoxyphenylamino)-4-oxobutanoic acid;4-(4-Methoxy-2-nitroanilino)-4-oxobutanoic acid
4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid化学式
CAS
——
化学式
C11H12N2O6
mdl
MFCD00425565
分子量
268.226
InChiKey
DBBWQXIPXFGNTL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.82
  • 重原子数:
    19.0
  • 可旋转键数:
    6.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.272
  • 拓扑面积:
    118.77
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid碳酸氢钠 作用下, 以 为溶剂, 生成 sodium N-[(2-methoxyphenyl)]-4-oxo-4-[oxyl]butanamide
    参考文献:
    名称:
    基于羧酸盐配体的 5 配位有机锡 (IV) 配合物的合成、表征和生物学筛选
    摘要:
    摘要 本文重点研究了基于羧酸盐配体4-((4-甲氧基-2-硝基苯基)氨基)-4-氧代丁酸的三种5-配位Sn(IV)配合物的合成。该配合物在固态(FT-IR、单晶 XRD 和微元素分析)和溶液态(1H、13C 和 119Sn NMR)中均进行了表征,结果表明配体的羧酸根部分与 Sn 相连原子。5 配位三角双锥结构是从晶体学数据获得的报告复合物与理想结构有一点点失真。初步抗真菌筛选表明,如众所周知的抗真菌药物特比萘芬所示,受试化合物具有 100% 的真菌抑制能力。抑菌结果表明,与市售的标准抗菌药物头孢克肟和罗克霉素相比,这些化合物对多种病原体具有突出的抑制能力。针对 H157 癌细胞系的抗增殖/抗癌结果显示,化合物 1 和 2 显示出最大的活性(即使在 2 μg/mL 终浓度下也具有 49-69% 的细胞毒性)。发现测试化合物对人角膜上皮细胞 (HCEC) 具有活性。合成的化合物对HCEC几乎无毒。当以
    DOI:
    10.1016/j.molstruc.2020.127683
  • 作为产物:
    描述:
    丁二酸酐2-硝基-4-甲氧基苯胺溶剂黄146 作用下, 以90%的产率得到4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid
    参考文献:
    名称:
    Synthesis, spectroscopic characterization and in vitro antimicrobial, anticancer and antileishmanial activities as well interaction with Salmon sperm DNA of newly synthesized carboxylic acid derivative, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid
    摘要:
    This paper stresses on the synthesis, characterization of novel carboxylic acid derivative and its application in pharmaceutics. Carboxylic acid derivatives have a growing importance in medicine, particularly in oncology. A novel carboxylic acid, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid, was synthesized and characterized by elemental analysis, FT-IR, NMR (H-1, and C-13), mass spectrometry and single crystal X-ray structural analysis. The structure of the title compound, C11H12N2O6, shows the molecules dimerised by short intramolecular O-H center dot center dot center dot O hydrogen bonds. The compound was screened for in vitro antimicrobial, anticancer, and antileishmanial activities as well as interaction with SS-DNA. The compound was also checked for in vitro anticancer activity against BHK-21, H-157 and HCEC cell lines, and showed significant anticancer activity. The compound was almost non-toxic towards human corneal epithelial cells (HCEC) and did not show more than 7.4% antiproliferative activity when used at the 2.0 mu g/mL end concentration. It was also tested for antileishmanial activity against the promastigote form of leishmania major and obtained attractive result. DNA interaction study exposes that the binding mode of the compound with SS-DNA is an intercalative as it results in hypochromism along with minor red shift. A new and efficient strategy to identify pharmacophores sites in carboxylic acid derivative for antibacterial/antifungal activity using Petra, Osiris and Molinspiration (POM) analyses was also carried out. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.saa.2014.11.061
点击查看最新优质反应信息

文献信息

  • Facile esterification of carboxylic acids with organophosphorus reagents
    作者:V. Balasubramaniyan、V.G. Bhatia、S.B. Wagh
    DOI:10.1016/s0040-4020(01)88552-5
    日期:1983.1
    A mixture of alkyl phosphate esters (APE) obtained from P4O10 and alkanols taken in 1:6 mole ratio is an excellent esterification reagent for several classes of carboxylic acids. This new reagent offers several advantages compared to conventional reagents.
    由P 4 O 10获得的烷基磷酸酯(APE)和以1:6摩尔比获得的链烷醇的混合物是用于几类羧酸的优良酯化试剂。与常规试剂相比,这种新试剂具有多个优点。
  • Synthesis, characterization and biological screenings of 5-coordinated Organotin(IV) complexes based on carboxylate ligand
    作者:Muhammad Sirajuddin、Saqib Ali、Vickie McKee、Abdul Matin
    DOI:10.1016/j.molstruc.2020.127683
    日期:2020.4
    Abstract This article focus on the synthesis of three 5-coordinated Sn(IV) complexes based on carboxylate ligand: 4-((4-methoxy-2-nitrophenyl)amino)-4-oxobutanoic acid. The complexes were characterized both in solid state (FT-IR, single crystal XRD and micro elemental analysis) as well as in solution state (1H, 13C and 119Sn NMR) and their results demonstrate that the carboxylate moiety of the ligand
    摘要 本文重点研究了基于羧酸盐配体4-((4-甲氧基-2-硝基苯基)氨基)-4-氧代丁酸的三种5-配位Sn(IV)配合物的合成。该配合物在固态(FT-IR、单晶 XRD 和微元素分析)和溶液态(1H、13C 和 119Sn NMR)中均进行了表征,结果表明配体的羧酸根部分与 Sn 相连原子。5 配位三角双锥结构是从晶体学数据获得的报告复合物与理想结构有一点点失真。初步抗真菌筛选表明,如众所周知的抗真菌药物特比萘芬所示,受试化合物具有 100% 的真菌抑制能力。抑菌结果表明,与市售的标准抗菌药物头孢克肟和罗克霉素相比,这些化合物对多种病原体具有突出的抑制能力。针对 H157 癌细胞系的抗增殖/抗癌结果显示,化合物 1 和 2 显示出最大的活性(即使在 2 μg/mL 终浓度下也具有 49-69% 的细胞毒性)。发现测试化合物对人角膜上皮细胞 (HCEC) 具有活性。合成的化合物对HCEC几乎无毒。当以
  • Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer’s Disease: Synthesis, Characterization, Computational and in vitro Approaches
    作者:Rehman Zafar、Humaira Naureen、Muhammad Zubair、Khadija Shahid、Muhammad Saeed Jan、Samar Akhtar、Hammad Ahmad、Wajeeha Waseem、Ali Haider、Saqib Ali、Muhammad Tariq、Abdul Sadiq
    DOI:10.2147/dddt.s311619
    日期:——
    complexes which were potentially analyzed for various biological applications like acetylcholinesterase (AChE), butyrylcholinesterase (BChE) inhibitory potentials, and antioxidant assays. Computational docking studies also simulated results to understand the interactions. Additionally, thermodynamic parameters utilizing molecular dynamic simulation were performed to determine the ligand protein stability
    背景:阿尔茨海默病 (AD) 是一种主要由痴呆症描述的神经退行性疾病。尽管阿尔茨海默病已为人所知一个多世纪,但它的起源仍然是个谜,研究人员正在探索许多治疗方案,包括胆碱酯酶技术。乙酰胆碱 ACh 神经递质水平降低被认为是阿尔茨海默病进展的重要因素之一。 方法:在继续合成潜在的抗阿尔茨海默病药物和已知的含酰胺化合物的药理潜力的过程中,本研究介绍了两种新型酰胺基过渡金属锌 (II) 配合物 AAZ7 和 AAZ8 的合成,它们与杂环吡啶环相连,通过傅里叶变换红外光谱(FT-IR)、元素分析、1 H_NMR和13 C_NMR对其进行合成和表征。FT-IR 光谱记录显示,与游离配体相比,两种配合物中的 Δν 值都降低了,形成了二齿配体。分析了两种合成的复合物的乙酰胆碱酯酶和丁酰胆碱酯酶抑制潜力以及抗氧化活性。 结果:重要的是,与标准阳性对照加兰他敏相比,AAZ8 复合物表现出更强的活性,作为 AChE
  • Synthesis, physicochemical characterizations and in vitro biological evaluations of amide based Zn(II) carboxylates
    作者:Muhammad Zubair、Muhammad Sirajuddin、Ali Haider、Kaleem Ullah、Irfan Ullah、Akhtar Munir、Saqib Ali、Muhammad Nawaz Tahir
    DOI:10.1016/j.ica.2018.07.005
    日期:2018.10
    Carboxylate ligands are widely used in chemistry and pharmacy owing to their ability to form stable complexes with a large variety of metal ions. In that context, carboxylate complexes allow modulation of the pharmaceutical products. Herein, a series of six novel Zn(II) carboxylates: [Zn(L-1)(2)] (1), [Zn(L-1)(2) (bipy)] (2), [Zn(L-1)(2) (phen)] (3), [Zn(L-2)(2)] (4), [Zn(L-2)(2) (bipy)] (5) and [Zn(L-2)(2) (phen)] (6) (where L-1 = 4-(2-methoxy-5-nitrophenylamino)-4-oxobutanoic acid), L-2 = 4-(2-nitro-4-methoxyphenylamino)-4-oxobutanoic acid), phen = 1,10-phenanthroline and bipy = 2,2'-bipyridine) were synthesized in good yield and successfully characterized by H-1, C-13 NMR, FT-IR and single-crystal X-ray crystallography. The spectroscopic data reveal that the absence of OH peak in the spectra of complexes confirm their formation. Single-crystal X-ray crystallographic data for complexes 1 and 5 show a distorted octahedral environment around the Zn atom. The results of both FTIR and single-crystal X-ray crystallography confirm the bidentate nature of the carboxylate ligands. The DNA interaction study of the synthesized complexes was investigated using UV-visible spectroscopy and viscosity measurements suggesting an intercalative binding mode of interaction of the complexes with SS-DNA. The interaction between the synthesized complexes and CTAB was elaborately studied with a conductometric method. The conductivity method was used to find CMC, higher CMC values suggesting a stable complex-CTAB system. Results of in vitro antibacterial and antifungal activities indicate the biological potency of the synthesized compounds.
  • BALASUBRAMANIYAN, V.;BHATIA, V. G.;WAGH, S. B., TETRAHEDRON, 1983, 39, N 9, 1475-1485
    作者:BALASUBRAMANIYAN, V.、BHATIA, V. G.、WAGH, S. B.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐